Global Automated Insulin Delivery Devices Market, By Type (Pens, Insulin Pumps, Pen Needles, Insulin Syringes and Others), End-User (Homecare, Hospitals, and Clinics), and Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Automated Insulin Delivery Devices Market
The automated insulin delivery devices market is expected to witness market growth at a rate of 5% in the forecast period of 2021 to 2028. Data Bridge Market Research report on automated insulin delivery devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in awareness programs and campaigns about diabetes and its complications is escalating the growth of the automated insulin delivery devices market.
An automated insulin delivery device is also referred to as a hybrid closed loop. It is used for maintaining the glucose level in the blood and to reduce cases of hypoglycemia.
Major factors that are expected to boost the growth automated insulin delivery devices market in the forecast period are the rise in the prevalence of diabetes around the globe. Furthermore, the invention in product launches is further anticipated to propel the growth of the automated insulin delivery devices market. Moreover, the technological developments in insulin delivery devices are further estimated to cushion the growth of the automated insulin delivery devices market. On the other hand, oral insulin as a substitute drug delivery process is further projected to impede the growth of the automated insulin delivery devices market in the timeline period.
In addition, the rise in the awareness programs and reimbursement scenario in advanced countries will further provide potential opportunities for the growth of the automated insulin delivery devices market in the coming years. However, the reuse of pen needles and infusion sets might further challenge the growth of the automated insulin delivery devices market in the near future.
This automated insulin delivery devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the healthcare analytical testing services market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth.
Automated Insulin Delivery Devices Market Scope and Market Size
The automated insulin delivery devices market is segmented on the basis of type and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
- On the basis of type, the automated insulin delivery devices market is segmented into pens, insulin pumps, pen needles, insulin syringes, and others.
- On the basis of end-users, the automated insulin delivery devices market is segmented into home care, hospitals, and clinics.
Automated Insulin Delivery Devices Market Country Level Analysis
The automated insulin delivery devices market is analysed, and market size insights and trends are provided by country, type, and end-user as referenced above.
The countries covered in the automated insulin delivery devices market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and rest of South America as part of South America.
North America dominates the automated insulin delivery devices market due to the rise in the diabetic population. Moreover, the availability of technologically advanced devices will further boost the growth of the automated insulin delivery devices market in the region during the forecast period. Asia-Pacific is projected to observe a significant amount of growth in the automated insulin delivery devices market due to the rise in the population. Moreover, the growth of the geriatric and diabetic population is further anticipated to propel the growth of the automated insulin delivery devices market in the region in the coming years.
The country section of the automated insulin delivery devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The automated insulin delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for automated insulin delivery devices market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the automated insulin delivery devices market. The data is available for the historic period 2010-2019.
Competitive Landscape and Automated Insulin Delivery Devices Market Share Analysis
The automated insulin delivery devices market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the automated insulin delivery devices market.
The major players covered in the automated insulin delivery devices market report are Novo Nordisk A/S, Sanofi, Lilly, Biocon, Ypsomed, Wockhardt, Digital Medics, Abbott, Companion Medical, F. Hoffmann-La Roche, Ltd., BD, Animas LLC, Medtronic., Tandem Diabetes Care, Inc, Diabetes Care, BIGFOOT BIOMEDICAL, INC., DreaMed Diabetes, Ltd, and WTWH Media LLC among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-